Adaptimmune Therapeutics PLC (NASDAQ:ADAP)
| 2.92 BATS BZX Real-Time Price As of 10:14am ET |  -0.03 / -1.02%Today’s Change | 2.89 Today|||52-Week Range 7.34 | -22.13% Year-to-Date |
Latest ADAP News | Press Releases
| 2 Cancer Stocks With Absurdly Low Valuations Jan 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.95 |
| Today’s open | 2.95 |
| Day’s range | 2.89 - 2.95 |
| Volume | 7,274 |
| Average volume (3 months) | 923,262 |
| Market cap | $506.1M |
Data as of 10:14am ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | +30.12% |
| Earnings growth (this year) | +89.33% |
| Earnings growth (next 5 years) | +5.60% |
| Revenue growth (last year) | +252.76% |
| P/E ratio | NM |
| Price/Sales | 194.01 |
| Price/Book | 1.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SIGASIGA Technologies In... | +0.10 | +1.59% |
| VBIVVBI Vaccines Inc | -0.05 | -2.72% |
| DCPHDeciphera Pharmaceut... | -0.02 | -0.25% |
| ---- |
Data as of 10:15am ET, 01/21/2022
Financials
| Next reporting date | March 16, 2022 |
| EPS forecast (this quarter) | $0.12 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$130.1M |
| Net profit margin | -3,286.81% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Abingdon, Oxfordshire |
Forecasts
